Clinical Trial Update: Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Gliadel Wafer in combination with O6-Benzylguanine for recurrent glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• GLIADEL wafer (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: Duke University | Conditions: Recurrent Adult Brain Tumor | Phase 2 | Status: COMPLETED